121 related articles for article (PubMed ID: 35974288)
1. Elevated Levels of Naturally-Occurring Autoantibodies Against the Extracellular Domain of p75NTR Aggravate the Pathology of Alzheimer's Disease.
He CY; Tian DY; Chen SH; Jin WS; Cheng Y; Xin JY; Li WW; Zeng GH; Tan CR; Jian JM; Fan DY; Ren JR; Liu YH; Wang YJ; Zeng F
Neurosci Bull; 2023 Feb; 39(2):261-272. PubMed ID: 35974288
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
[TBL] [Abstract][Full Text] [Related]
3. p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease.
Yao XQ; Jiao SS; Saadipour K; Zeng F; Wang QH; Zhu C; Shen LL; Zeng GH; Liang CR; Wang J; Liu YH; Hou HY; Xu X; Su YP; Fan XT; Xiao HL; Lue LF; Zeng YQ; Giunta B; Zhong JH; Walker DG; Zhou HD; Tan J; Zhou XF; Wang YJ
Mol Psychiatry; 2015 Nov; 20(11):1301-10. PubMed ID: 25917367
[TBL] [Abstract][Full Text] [Related]
4. Cysteine-Rich Repeat Domains 2 and 4 are Amyloid-β Binding Domains of Neurotrophin Receptor p75NTR and Potential Targets to Block Amyloid-β Neurotoxicity.
Wang YR; Wang J; Liu YH; Hu GL; Gao CY; Wang YJ; Zhou XF; Zeng F
J Alzheimers Dis; 2018; 63(1):139-147. PubMed ID: 29578485
[TBL] [Abstract][Full Text] [Related]
5. p75NTR Ectodomain Ameliorates Cognitive Deficits and Pathologies in a Rapid Eye Movement Sleep Deprivation Mice Model.
Zhu Y; Gao M; Huang H; Gao SH; Liao LY; Tao Y; Cheng H; Gao CY
Neuroscience; 2022 Aug; 496():27-37. PubMed ID: 35697320
[TBL] [Abstract][Full Text] [Related]
6. Repetitive Transcranial Magnetic Stimulation Decreases Serum Amyloid-β and Increases Ectodomain of p75 Neurotrophin Receptor in Patients with Alzheimer's Disease.
Tao Y; Lei B; Zhu Y; Fang X; Liao L; Chen D; Gao C
J Integr Neurosci; 2022 Jul; 21(5):140. PubMed ID: 36137949
[TBL] [Abstract][Full Text] [Related]
7. Amyloid beta₁₋₄₂ (Aβ₄₂) up-regulates the expression of sortilin via the p75(NTR)/RhoA signaling pathway.
Saadipour K; Yang M; Lim Y; Georgiou K; Sun Y; Keating D; Liu J; Wang YR; Gai WP; Zhong JH; Wang YJ; Zhou XF
J Neurochem; 2013 Oct; 127(2):152-62. PubMed ID: 23895422
[TBL] [Abstract][Full Text] [Related]
8. A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression.
Simmons DA; Knowles JK; Belichenko NP; Banerjee G; Finkle C; Massa SM; Longo FM
PLoS One; 2014; 9(8):e102136. PubMed ID: 25153701
[TBL] [Abstract][Full Text] [Related]
9. Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.
Shen LL; Li WW; Xu YL; Gao SH; Xu MY; Bu XL; Liu YH; Wang J; Zhu J; Zeng F; Yao XQ; Gao CY; Xu ZQ; Zhou XF; Wang YJ
Neurobiol Dis; 2019 Dec; 132():104567. PubMed ID: 31394202
[TBL] [Abstract][Full Text] [Related]
10. Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.
Wang T; Xie XX; Ji M; Wang SW; Zha J; Zhou WW; Yu XL; Wei C; Ma S; Xi ZY; Pang GL; Liu RT
Neuropharmacology; 2016 Jun; 105():561-576. PubMed ID: 26907803
[TBL] [Abstract][Full Text] [Related]
11. Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.
Jian JM; Fan DY; Cheng Y; Shen YY; Chen DW; Li HY; Chen Y; Zhang Y; Zeng GH; Tan CR; Liu YH; Wang YJ
J Alzheimers Dis; 2022; 87(2):711-719. PubMed ID: 35342089
[TBL] [Abstract][Full Text] [Related]
12. Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.
Dodel R; Balakrishnan K; Keyvani K; Deuster O; Neff F; Andrei-Selmer LC; Röskam S; Stüer C; Al-Abed Y; Noelker C; Balzer-Geldsetzer M; Oertel W; Du Y; Bacher M
J Neurosci; 2011 Apr; 31(15):5847-54. PubMed ID: 21490226
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid-beta peptides via p75NTR/PLAIDD.
Hashimoto Y; Kaneko Y; Tsukamoto E; Frankowski H; Kouyama K; Kita Y; Niikura T; Aiso S; Bredesen DE; Matsuoka M; Nishimoto I
J Neurochem; 2004 Aug; 90(3):549-58. PubMed ID: 15255932
[TBL] [Abstract][Full Text] [Related]
14. Naturally-Occurring Antibodies Against Bim are Decreased in Alzheimer's Disease and Attenuate AD-type Pathology in a Mouse Model.
Jian JM; Fan DY; Tian DY; Cheng Y; Sun PY; Tan CR; Zeng GH; He CY; Wang YR; Zhu J; Yao XQ; Wang YJ; Liu YH
Neurosci Bull; 2022 Sep; 38(9):1025-1040. PubMed ID: 35570231
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration.
Capsoni S; Tiveron C; Vignone D; Amato G; Cattaneo A
Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12299-304. PubMed ID: 20566851
[TBL] [Abstract][Full Text] [Related]
16. Association between naturally occurring anti-amyloid β autoantibodies and medial temporal lobe atrophy in Alzheimer's disease.
Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Inuzuka T
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):126-131. PubMed ID: 27330118
[TBL] [Abstract][Full Text] [Related]
17. Relative expression of the p75 neurotrophin receptor, tyrosine receptor kinase A, and insulin receptor in SH-SY5Y neuroblastoma cells and hippocampi from Alzheimer's disease patients.
Ito S; Ménard M; Atkinson T; Brown L; Whitfield J; Chakravarthy B
Neurochem Int; 2016 Dec; 101():22-29. PubMed ID: 27693452
[TBL] [Abstract][Full Text] [Related]
18. p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Abeta aggregation with its extracellular domain.
Wang YJ; Wang X; Lu JJ; Li QX; Gao CY; Liu XH; Sun Y; Yang M; Lim Y; Evin G; Zhong JH; Masters C; Zhou XF
J Neurosci; 2011 Feb; 31(6):2292-304. PubMed ID: 21307265
[TBL] [Abstract][Full Text] [Related]
19. Differential levels of p75NTR ectodomain in CSF and blood in patients with Alzheimer's disease: a novel diagnostic marker.
Jiao SS; Bu XL; Liu YH; Wang QH; Liu CH; Yao XQ; Zhou XF; Wang YJ
Transl Psychiatry; 2015 Oct; 5(10):e650. PubMed ID: 26440538
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Study of the Pharmacokinetics of p75ECD-Fc, a Novel Human Recombinant Protein for Treatment of Alzheimer's Disease, in Sprague Dawley Rats.
Kelliny S; Lam HY; Parikh A; Wang YJ; Bobrovskaya L; Upton R; Zhou XF
Curr Drug Metab; 2020; 21(3):235-244. PubMed ID: 32357812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
